“…Noninvasive imaging, in particular clinical molecular imaging, is poised to accelerate translation of basic research, demonstrated by 2 recent studies published in Circulation: Cardiovascular Imaging. 9,10 Both studies rely on 18 F-fluorodeoxyglucose ( 18 F-FDG), a positron emission tomography (PET) tracer that is in clinical use for cancer staging. The 18 F isotope-labeled imaging agent uses glucose transporters for uptake into cells with high glucose metabolism.…”